Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Risk Stratification of Diffuse Large B-Cell Lymphoma Based on Cell Surface Markers Using Flow Cytometry

Tomoyo Kubo, Yoshimitsu Shimomura, Hayato Maruoka, Yuya Nagai, Tadakazu Kondo, Takayuki Ishikawa

Blood (2022) 140 (Supplement 1): 3842–3843.

https://doi.org/10.1182/blood-2022-162248

Published: 2022

Journal Articles

Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies

Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, Satoshi Mitsuyuki, Tomoyo Kubo, Naoki Okada, Daishi Nakagawa, Kimimori Kamijo, Hiroharu Imoto, Yuya Nagai, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Tadakazu Kondo, Takayuki Ishikawa

Blood (2022) 140 (Supplement 1): 2633–2634.

https://doi.org/10.1182/blood-2022-162172

Published: 2022

Journal Articles

High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies

Takuto Mori, MD, Yuichiro Ono, MD, Hayato Maruoka, PhD, Yoshimitsu Shimomura, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD PhD, June Takeda, MD, Yasuhito Nannya, MD PhD, Seishi Ogawa, MD PhD, Takayuki Ishikawa

Blood (2018) 132 (Supplement 1): 1485.

https://doi.org/10.1182/blood-2018-99-112031

Published: 2018

Journal Articles

Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia

Yoshimitsu Shimomura, MD, Hayato Maruoka, PhD, Tomohiro Yabushita, MD, Hisako Hashimoto, Takayuki Ishikawa, MD PhD

Blood (2017) 130 (Supplement 1): 2000.

https://doi.org/10.1182/blood.V130.Suppl_1.2000.2000

Published: 2017

Journal Articles

The Prognostic Significance of the Complete IgH Rearrangement Pattern Using the BIOMED-2 Protocol in Diffuse Large B-Cell Lymphoma

Tomohiro Yabushita, MD, Hayato Maruoka, PhD, Yoshimitsu Shimomura, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD PhD, Hisako Hashimoto, MD PhD, Takayuki Ishikawa, MD PhD

Blood (2017) 130 (Supplement 1): 420.

https://doi.org/10.1182/blood.V130.Suppl_1.420.420

Published: 2017

Journal Articles

Detection of Cells with Low Side Scatter and Dimmer CD45 Expression after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Good Survival

Yoshimitsu Shimomura, MD, Hayato Maruoka, M.T, Yotaro Ochi, MD, Yusuke Koba, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 3207.

https://doi.org/10.1182/blood.V126.23.3207.3207

Published: 2015

Journal Articles

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Yuichiro Ono, MD, Daisuke Kato, MD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Yukihiro Imai, MD, PhD, Hayato Maruoka, M.T, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 1480.

https://doi.org/10.1182/blood.V126.23.1480.1480

Published: 2015

Journal Articles

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

Yuichiro Ono, M.D., June Takeda, M.D., Hayato Maruoka, Yasuhiro Kazuma, M.D., Nobuhiro Hiramoto, MD, Nobuhiko Yamauchi, M.D., Yosuke Nagahata, M.D., Yuki Funayama, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Koji Nasu, Takayuki Takahashi, M.D., Ph.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 3921.

https://doi.org/10.1182/blood.V122.21.3921.3921

Published: 2013

Journal Articles

Impact of Occult Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Hiroshi Arima, MD, Hayato Maruoka, Koji Nasu, Yuki Funayama, MD, June Takeda, MD, Nobuhiko Yamauchi, MD, Kazunari Aoki, MD, Aiko Kato, MD, Yuichiro Ono, MD, Seiji Nagano, MD, Yoko Takiuchi, MD, Sumie Tabata, MD, PhD, Akiko Matsushita, MD, Yukihiro Imai, MD, PhD, Takayuki Takahashi, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2011) 118 (21): 1578.

https://doi.org/10.1182/blood.V118.21.1578.1578

Published: 2011

NARROW

Risk Stratification of Diffuse Large B-Cell Lymphoma Based on Cell Surface Markers Using Flow Cytometry

Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies

High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies

Minimal Residual Disease after Allogeneic Stem Cell Transplantation Was Associated with Poor Outcomes in Patients with Acute Myeloid Leukemia

The Prognostic Significance of the Complete IgH Rearrangement Pattern Using the BIOMED-2 Protocol in Diffuse Large B-Cell Lymphoma

Detection of Cells with Low Side Scatter and Dimmer CD45 Expression after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Good Survival

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

Impact of Occult Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only